FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Geerten van Nieuw Amerongen

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Jurjan Aman; Amin Damanafshan; Etto C Eringa; A B Johan Groeneveld; Stephan Huveneers; Jan van Bezu; Victor W M van Hinsbergh; Steven M Vogel; Anton Vonk-Noordegraaf; Geerten P van Nieuw Amerongen
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
Jurjan Aman; Marinus A Paul; Erik Thunnissen; Geerten P van Nieuw Amerongen; Anton Vonk-Noordegraaf
Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab.
Zhenlong Chen; Asrar B Malik; Mao Mao; Ayesha N Shajahan; Tiffany Sharma; Randal A Skidgel; Andy Trane; Geerten P van Nieuw Amerongen; Farnaz R Bakhshi; Pascal N Bernatchez; Marcelo Bonini; Richard D Minshall
Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Geerten van Nieuw Amerongen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jurjan Aman; Amin Damanafshan; Etto C Eringa; A B Johan Groeneveld; Stephan Huveneers; Jan van Bezu; Victor W M van Hinsbergh; Steven M Vogel; Anton Vonk-Noordegraaf; Geerten P van Nieuw Amerongen
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
Circulation 2012;126(23):2728-38.
2012: Jurjan Aman; Marinus A Paul; Erik Thunnissen; Geerten P van Nieuw Amerongen; Anton Vonk-Noordegraaf
Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab.
Annals of internal medicine 2012;156(11):839-40.
2012: Zhenlong Chen; Asrar B Malik; Mao Mao; Ayesha N Shajahan; Tiffany Sharma; Randal A Skidgel; Andy Trane; Geerten P van Nieuw Amerongen; Farnaz R Bakhshi; Pascal N Bernatchez; Marcelo Bonini; Richard D Minshall
Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition.
Molecular biology of the cell 2012;23(7):1388-98.
2012: Jurjan Aman; A B Johan Groeneveld; Geerten P van Nieuw Amerongen
Predictors of pulmonary edema formation during fluid loading in the critically ill with presumed hypovolemia*.
Critical care medicine 2012;40(3):793-9.
2011: Melanie van der Heijden; A B Johan Groeneveld; Marinus A Paul; Jan van Bezu; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh
Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells.
PloS one 2011;6(8):e23448.
2011: Jurjan Aman; Marcel G A van der Heijden; Arthur van Lingen; Armand R J Girbes; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; A B Johan Groeneveld
Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome.
Critical care medicine 2011;39(1):89-97.
2011: Ramaswamy Krishnan; Darinka D Klumpers; Chan Y Park; Kavitha Rajendran; Xavier Trepat; Jan van Bezu; Victor W M van Hinsbergh; Christopher V Carman; Joseph D Brain; Jeffrey J Fredberg; James P Butler; Geerten P van Nieuw Amerongen
Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces.
American journal of physiology. Cell physiology 2011;300(1):C146-54.
2010: Ester M Weijers; PIETER KOOLWIJK; Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al.
International journal of cancer. Journal international du cancer 2010;127(12):2981-2; author reply 2982-6.
2010: Paul A J Krijnen; Jessica A Sipkens; Johan W Molling; Jan A Rauwerda; Coen D A Stehouwer; Alice Muller; Walter J Paulus; Geerten P van Nieuw Amerongen; C Erik Hack; Arthur J Verhoeven; Victor W M van Hinsbergh; Hans W M Niessen
Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
Journal of molecular and cellular cardiology 2010;49(5):781-90.
2010: K T B Mouchaers; I Schalij; M A de Boer; Pieter E Postmus; V W M van Hinsbergh; Geerten P van Nieuw Amerongen; Anton Vonk-Noordegraaf; Willem J van der Laarse
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;36(4):800-7.
2010: Richard D Minshall; Emily E Vandenbroucke; Michael Holinstat; Aaron T Place; Chinnaswamy Tiruppathi; Stephen M Vogel; Geerten P van Nieuw Amerongen; Dolly Mehta; Asrar B Malik
Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers.
Microvascular research 2010;80(2):240-9.
2010: Eloise A Bradley; Etto C Eringa; Coen D A Stehouwer; Iolente Korstjens; Geerten P van Nieuw Amerongen; Rene Musters; Pieter Sipkema; Michael G Clark; Stephen Rattigan
Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(6):1137-42.
2010: Reinier A Boon; Thomas A Leyen; Ruud D Fontijn; Joost O Fledderus; Josefien M C Baggen; Oscar L Volger; Geerten P van Nieuw Amerongen; Anton J G Horrevoets
KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium.
Blood 2010;115(12):2533-42.
2010: Marcel G A van der Heijden; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; A B Johan Groeneveld
The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients.
Shock (Augusta, Ga.) 2010;33(3):263-8.
2010: Geerten P van Nieuw Amerongen; A B Johan Groeneveld
A plethora of angiopoietin-2 effects during clinical sepsis.
Critical care (London, England) 2010;14(3):166.
2010: Cora M L Beckers; Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Driving Rho GTPase activity in endothelial cells regulates barrier integrity.
Thrombosis and haemostasis 2010;103(1):40-55.
2009: Marcel G A van der Heijden; Peter Pickkers; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Martijn P W J M Bouw; Johannes G van der Hoeven; A B Johan Groeneveld
Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.
Intensive care medicine 2009;35(9):1567-74.
2009: Ronald Vlasblom; Alice Muller; Cora M L Beckers; Geerten P van Nieuw Amerongen; Marian J Zuidwijk; Cornelis Van Hardeveld; Walter J Paulus; Warner S Simonides
RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes.
Pflügers Archiv : European journal of physiology 2009;458(4):785-93.
2009: Koen T B Mouchaers; Ingrid Schalij; Amanda M G Versteilen; Awal M Hadi; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Pieter E Postmus; Willem J van der Laarse; Anton Vonk-Noordegraaf
Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension.
American journal of physiology. Heart and circulatory physiology 2009;297(1):H200-7.
2009: Marcel G A van der Heijden; Joanne Verheij; Geerten P van Nieuw Amerongen; A B Johan Groeneveld
Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia.
Critical care medicine 2009;37(4):1275-81.
2009: Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh
Role of ROCK I/II in vascular branching.
American journal of physiology. Heart and circulatory physiology 2009;296(4):H903-5.
2009: Alexander D Cornet; Armand Rj Girbes; Marcus J Schultz; Geerten P van Nieuw Amerongen; albertus beishuizen; Ab Johan Groeneveld
Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome.
Expert opinion on drug discovery 2009;4(3):219-27.
2008: Marcel G A van der Heijden; Geerten P van Nieuw Amerongen; PIETER KOOLWIJK; Victor W M van Hinsbergh; A B Johan Groeneveld
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
Thorax 2008;63(10):903-9.
2008: Marcel N A Bijman; Maria P A van Berkel; Geerten P van Nieuw Amerongen; Epie Boven
Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility.
Biochemical pharmacology 2008;76(6):707-16.
2008: Cora M L Beckers; Juan Jesus Garcia Vallejo; Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction.
Cardiovascular research 2008;79(4):679-88.
2008: Maria J Overbeek; Geerten P van Nieuw Amerongen; a boonstra; Egbert F Smit; Anton Vonk-Noordegraaf
Possible role of imatinib in clinical pulmonary veno-occlusive disease.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2008;32(1):232-5.
2008: Geerten P van Nieuw Amerongen; René J P Musters; Etto C Eringa; Pieter Sipkema; Victor W M van Hinsbergh
Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis.
American journal of physiology. Cell physiology 2008;294(5):C1234-41.
2008: Marcel G A van der Heijden; Amanda M G Versteilen; Pieter Sipkema; Geerten P van Nieuw Amerongen; René J P Musters; A B Johan Groeneveld
Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis.
Apoptosis : an international journal on programmed cell death 2008;13(3):404-12.
2007: Geerten P van Nieuw Amerongen; C M L Beckers; I D Achekar; S Zeeman; René J P Musters; Victor W M van Hinsbergh
Involvement of Rho kinase in endothelial barrier maintenance.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(11):2332-9.
2007: Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh
Endogenous RhoA inhibitor protects endothelial barrier.
Circulation research 2007;101(1):7-9.
2006: Marcel N A Bijman; Geerten P van Nieuw Amerongen; Nancy Laurens; Victor W M van Hinsbergh; Epie Boven
Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton.
Molecular cancer therapeutics 2006;5(9):2348-57.
2006: E P van de Visse; Marcel G A van der Heijden; Joanne Verheij; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Armand R J Girbes; A B Johan Groeneveld
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;27(5):1026-32.
2006: Kitty Kapiteijn; PIETER KOOLWIJK; Robin M F van der Weiden; Geerten P van Nieuw Amerongen; Margreet Plaisier; Victor W M van Hinsbergh; Frans M Helmerhorst
Human embryo-conditioned medium stimulates in vitro endometrial angiogenesis.
Fertility and sterility 2006;85 Suppl 1():1232-9.
2006: Etto C Eringa; Coen D A Stehouwer; Kimberley Walburg; Andrew D Clark; Geerten P van Nieuw Amerongen; Nico Westerhof; Pieter Sipkema
Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-alpha dependence on c-Jun N-terminal kinase.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):274-80.
2006: Matthias Gabriel; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Arie V Van Nieuw Amerongen; Andrej Zentner
Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films.
Journal of biomaterials science. Polymer edition 2006;17(5):567-77.
2004: Etto C Eringa; Coen D A Stehouwer; Geerten P van Nieuw Amerongen; Lenneke Ouwehand; Nico Westerhof; Pieter Sipkema
Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium.
American journal of physiology. Heart and circulatory physiology 2004;287(5):H2043-8.
2004: Christa Boer; Geerten P van Nieuw Amerongen; A B Johan Groeneveld; Gert Jan Scheffer; Jaap J de Lange; Nico Westerhof; Victor W M van Hinsbergh; Pieter Sipkema
Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance.
American journal of physiology. Lung cellular and molecular physiology 2004;287(4):L649-55.
2004: Vincent van Weel; Martine M L Deckers; Jos M Grimbergen; Kees J M van Leuven; JanWillem H P Lardenoye; Reinier O Schlingemann; Geerten P van Nieuw Amerongen; J Hajo van Bockel; Victor W M van Hinsbergh; Paul H A Quax
Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.
Circulation research 2004;95(1):58-66.
2004: Geerten P van Nieuw Amerongen; Kanchana Natarajan; Guoyong Yin; Ryan J Hoefen; Masaki Osawa; Judith Haendeler; A J Ridley; K Fujiwara; Victor W M van Hinsbergh; Bradford C Berk
GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions.
Circulation research 2004;94(8):1041-9.
2003: Geerten P van Nieuw Amerongen; PIETER KOOLWIJK; Amanda Versteilen; Victor W M van Hinsbergh
Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):211-7.
2002: Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function.
Vascular pharmacology 2002;39(4-5):257-72.
2002: Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Endothelial hyperpermeability in vascular leakage.
Vascular pharmacology 2002;39(4-5):171-2.
2002: Victor W M van Hinsbergh; Geerten P van Nieuw Amerongen
Intracellular signalling involved in modulating human endothelial barrier function.
Journal of anatomy 2002;200(6):549-60.
2000: Geerten P van Nieuw Amerongen; Mario Vermeer; P Nègre-Aminou; J Lankelma; Jef J Emeis; Victor W M van Hinsbergh
Simvastatin improves disturbed endothelial barrier function.
Circulation 2000;102(23):2803-9.
2000: Geerten P van Nieuw Amerongen; Mario Vermeer; Victor W M van Hinsbergh
Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(12):E127-33.
2000: Geerten P van Nieuw Amerongen; S van Delft; Mario Vermeer; John G Collard; Victor W M van Hinsbergh
Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases.
Circulation research 2000;87(4):335-40.
1998: Geerten P van Nieuw Amerongen; R Draijer; Mario Vermeer; Victor W M van Hinsbergh
Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA.
Circulation research 1998;83(11):1115-23.